ATC code C10

From Self-sufficiency
Revision as of 22:25, 16 August 2010 by EmausBot (Talk) (robot Adding: es:Anexo:Código ATC C10)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
ATC codes
C Cardiovascular system
C01 Cardiac therapy
C02 Antihypertensives
C03 Diuretics
C04 Peripheral vasodilators
C05 Vasoprotectives
C07 Beta blocking agents
C08 Calcium channel blockers
C09 Agents acting on the renin-angiotensin system
C10 Lipid modifying agents

A • B • C • D • G • H • QI • J • L • M • N • P • R • S • V

ATC code C10 Lipid modifying agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup C10 is part of the anatomical group C Cardiovascular system.[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QC10...[2]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

C10A Lipid modifying agents, plain

C10AA HMG CoA reductase inhibitors

C10AA01 Simvastatin
C10AA02 Lovastatin
C10AA03 Pravastatin
C10AA04 Fluvastatin
C10AA05 Atorvastatin
C10AA06 Cerivastatin
C10AA07 Rosuvastatin
C10AA08 Pitavastatin

C10AB Fibrates

C10AB01 Clofibrate
C10AB02 Bezafibrate
C10AB03 Aluminium clofibrate
C10AB04 Gemfibrozil
C10AB05 Fenofibrate
C10AB06 Simfibrate
C10AB07 Ronifibrate
C10AB08 Ciprofibrate
C10AB09 Etofibrate
C10AB10 Clofibride

C10AC Bile acid sequestrants

C10AC01 Colestyramine
C10AC02 Colestipol
C10AC03 Colextran
C10AC04 Colesevelam

C10AD Nicotinic acid and derivatives

C10AD01 Niceritrol
C10AD02 Nicotinic acid
C10AD03 Nicofuranose
C10AD04 Aluminium nicotinate
C10AD05 Nicotinyl alcohol (pyridylcarbinol)
C10AD06 Acipimox
C10AD52 Nicotinic acid, combinations

C10AX Other lipid modifying agents

C10AX01 Dextrothyroxine
C10AX02 Probucol
C10AX03 Tiadenol
C10AX05 Meglutol
C10AX06 Omega-3-triglycerides
C10AX07 Magnesium pyridoxal 5-phosphate glutamate
C10AX08 Policosanol
C10AX09 Ezetimibe
C10AX10 Alipogene tiparvovec

C10B Lipid modifying agents, combinations

C10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents

C10BA01 Lovastatin and nicotinic acid
C10BA02 Simvastatin and ezetimibe
C10BA03 Pravastatin and fenofibrate

C10BX HMG CoA reductase inhibitors, other combinations

C10BX01 Simvastatin and acetylsalicylic acid
C10BX02 Pravastatin and acetylsalicylic acid
C10BX03 Atorvastatin and amlodipine

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
GI tract
Liver
Niacin and derivatives (HDL and LDL)
Blood vessels
Combinations
Other

M: MET

mt, a/u/y/n/h, r/g/c/p/i, f/s/l/o, m

au/y/n/h, rgcp/i, f/s/l/o, m, epon

meds(A16, C10),intm(a/u/y/n/h, r/g/c/p/i, f/s/o)

ca:Codi ATC C10

cs:ATC kód C10 es:Anexo:Código ATC C10 hu:ATC C10 – A szérum-lipidszintet csökkentő szerek pl:ATC (C10) ro:Cod ATC C10 ru:Гиполипидемические препараты sv:ATC-kod C10: Medel som påverkar serumlipidnivåerna

th:ATC รหัส C10
  1. ↑ "ATC Index". WHO Collaborating Centre for Drug Statistics Methodology. 
  2. ↑ "ATCvet Index". WHO Collaborating Centre for Drug Statistics Methodology. 
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=ATC_code_C10&oldid=21199"